Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes

Annual Review of Food Science and Technology

Volumn 6, Issue , 2015, Pages 137-156

  Goh, Yong Jun ^a   Klaenhammer, Todd R ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Bifidobacterium; Fructooligosaccharide; Galactooligosaccharide; Lactobacillus; Prebiotic; Probiotic

Indexed keywords

BACTERIA; METABOLISM; OLIGOSACCHARIDES; SACCHARIFICATION;

BIFIDOBACTERIUM; FRUCTOOLIGOSACCHARIDES; GALACTO-OLIGOSACCHARIDES; LACTOBACILLUS; PREBIOTICS; PROBIOTIC;

PROBIOTICS;

BIFIDOBACTERIUM; LACTOBACILLUS;

OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT;

BIFIDOBACTERIUM; LACTOBACILLUS; METABOLISM;

BIFIDOBACTERIUM; LACTOBACILLUS; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS;

EID: 84928481662     PISSN: 19411413     EISSN: 19411421     Source Type: Journal    
DOI: 10.1146/annurev-food-022814-015706     Document Type: Review

References (104)

1. Abou Hachem M, Møller MS, Andersen JM, Fredslund F, Majumder A, et al. 2013. A snapshot into the metabolism of isomalto-oligosaccharides in probiotic bacteria. J. Appl. Glycosci. 60:95-100
2. AltermannE,RussellWM,Azcarate-PerilMA, Barrangou R, Buck BL, et al. 2005. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. PNAS 102:3906-12
3. Amaretti A, Bernardi T, Leonardi A, Raimondi S, Zanoni S, Rossi M. 2013. Fermentation of xylooligosaccharides by Bifidobacterium adolescentis DSMZ 18350: kinetics, metabolism, and -xylosidase activities. Appl. Microbiol. Biotechnol. 97:3109-17
4. Andersen JM, Barrangou R, Abou Hachem M, Lahtinen S, Goh YJ, et al. 2011. Transcriptional and functional analysis of galactooligosaccharide uptake by lacS in Lactobacillus acidophilus. PNAS 108:17785-90
5. Andersen JM, Barrangou R, Abou Hachem M, Lahtinen SJ, Goh YJ, et al. 2012. Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM. PLOS ONE 7:e44409
6. Andersen JM, Barrangou R, Abou Hachem M, Lahtinen SJ, Goh YJ, et al. 2013. Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactis Bl-04. BMC Genomics 14:312
7. Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, et al. 2011. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J. Biol. Chem. 286:34583-92
8. AshidaH,Miyake A, KiyoharaM,Wada J, Yoshida E, et al. 2009. Two distinctL-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19:1010-17
9. Azcarate-Peril MA, Altermann E, Goh YJ, Tallon R, Sanozky-Dawes RB, et al. 2008. Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl. Environ. Microbiol. 74:4610-25
10. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-20
11. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. PNAS 104:979-84
12. BarbozaM, Sela DA, PirimC, Locascio RG, Freeman SL, et al. 2009. Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specific, preferential consumption of glycans. Appl. Environ. Microbiol. 75:7319-25
13. Barrangou R, AltermannE,Hutkins R, Cano R, KlaenhammerTR. 2003. Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus. PNAS 100:8957-62
14. Barrangou R, Azcarate-PerilMA, Duong T, Conners SB, Kelly RM, Klaenhammer TR. 2006. Global analysis of carbohydrate utilization by Lactobacillus acidophilus using cDNA microarrays. PNAS 103:3816-21
15. Blatchford P, Ansell J, de Godoy MRC, Fahey G, Garcia-Mazcorro JF, et al. 2013. Prebiotic mechanisms, functions and applications. Int. J. Probiotics Prebiotics 8:109-32
16. Bode L. 2006. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J. Nutr. 136:2127-30
17. Boehm G, Stahl B. 2007. Oligosaccharides from milk. J. Nutr. 137:847S-49S
18. Burne RA, Penders JE. 1994. Differential localization of the Streptococcus mutans GS-5 fructan hydrolase enzyme, FruA. FEMS Microbiol. Lett. 121:243-49
19. Bustos Fernandez LM, Lasa JS, Man F. 2014. Intestinal microbiota: its role in digestive diseases. J. Clin. Gastroenterol. 48:657-66
20. Cantarel BL, Lombard V, Henrissat B. 2012. Complex carbohydrate utilization by the healthy human microbiome. PLOS ONE 7:e28742
21. Cecchini DA, Laville E, Laguerre S, Robe P, Leclerc M, et al. 2013. Functional metagenomics reveals novel pathways of prebiotic breakdown by human gut bacteria. PLOS ONE 8:e72766
22. Childs CE, Röyti ö H, Alhoniemi E, Fekete AA, Forssten SD, et al. 2014. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study. Br. J. Nutr. 111:1945-56
23. Davis LM, Martinez I, Walter J, Goin C, Hutkins RW. 2011. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLOS ONE 6:e25200
24. Dolejska M, Villa L, Minoia M, Guardabassi L, Carattoli A. 2014. Complete sequences of IncHI1 plasmids carrying blaCTX-M-1 and qnrS1 in equine Escherichia coli provide new insights into plasmid evolution. J. Antimicrob. Chemother. 69:2388-93
25. Ehrmann MA, Korakli M, Vogel RF. 2003. Identification of the gene for -fructofuranosidase of Bifidobacterium lactis DSM10140T and characterization of the enzyme expressed in Escherichia coli. Curr. Microbiol. 46:391-97
26. Ejby M, Fredslund F, Vujicic-Zagar A, Svensson B, Slotboom DJ, Abou Hachem M. 2013. Structural basis for arabinoxylo-oligosaccharide capture by the probiotic Bifidobacterium animalis subsp. lactis Bl-04. Mol. Microbiol. 90:1100-12
27. Francl AL,Hoeflinger JL,MillerMJ. 2012. Identification of lactose phosphotransferase systems in Lactobacillus gasseri ATCC 33323 required for lactose utilization. Microbiology 158:944-52
28. Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, Eom HJ, Block DE,Mills DA. 2013. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiol. 33:262-70
29. Gibson GR, Beatty ER, Wang X, Cummings JH. 1995. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108:975-82
30. Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125:1401-12
31. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, et al. 2010. Dietary prebiotics: current status and new definition. Food Sci. Technol. Bull. Funct. Foods 7:1-19
32. Gilad O, Jacobsen S, Stuer-Lauridsen B, Pedersen MB, Garrigues C, Svensson B. 2010. Combined transcriptome and proteome analysis of Bifidobacterium animalis subsp. lactis BB-12 grown on xylo-oligosaccharides and a model of their utilization. Appl. Environ. Microbiol. 76:7285-91
33. Goffin D, Delzenne N, Blecker C, Hanon E, Deroanne C, Paquot M. 2011. Will isomalto-oligosaccharides, a well-established functional food in Asia, break through the European and American market? The status of knowledge on these prebiotics. Crit. Rev. Food Sci. Nutr. 51:394-409
34. Goh YJ, Lee JH, Hutkins RW. 2007. Functional analysis of the fructooligosaccharide utilization operon in Lactobacillus paracasei 1195. Appl. Environ. Microbiol. 73:5716-24
35. Goh YJ, Zhang C, Benson AK, Schlegel V, Lee JH, Hutkins RW. 2006. Identification of a putative operon involved in fructooligosaccharide utilization by Lactobacillus paracasei. Appl. Environ.Microbiol. 72:7518-30
36. Goldsmith JR, Sartor RB. 2014. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J. Gastroenterol. 49:785-98
37. GonzalezR,Klaassens ES,Malinen E, de VosWM, Vaughan EE. 2008. Differential transcriptional response of Bifidobacterium longum to human milk, formula milk, and galactooligosaccharide. Appl. Environ.Microbiol. 74:4686-94
38. Gosling A, Stevens GW, Barber AR, Kentish SE, Gras SL. 2010. Recent advances refining galactooligosaccharide production from lactose. Food Chem. 121:307-18
39. Grenham S, Clarke G, Cryan JF, Dinan TG. 2011. Brain-gut-microbe communication in health and disease. Front. Physiol. 2:94
40. Hartemink R, Quataert MC, van Laere KM, Nout MJ, Rombouts FM. 1995. Degradation and fermentation of fructo-oligosaccharides by oral streptococci. J. Appl. Bacteriol. 79:551-57
41. Hidaka H, Hirayama M, Sumi N. 1988. A fructooligosaccharide-producing enzyme from Aspergillus niger ATCC 20611. Agric. Biol. Chem. 52:1181-87
42. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, et al. 2014. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11:506-14
43. Hinz SW, Pastink MI, van den Broek LA, Vincken JP, Voragen AG. 2005. Bifidobacterium longum endogalactanase liberates galactotriose from type I galactans. Appl. Environ. Microbiol. 71:5501-10
44. Imamura L, Hisamitsu K, Kobashi K. 1994. Purification and characterization of -fructofuranosidase from Bifidobacterium infantis. Biol. Pharm. Bull. 17:596-602
45. Janer C, Rohr LM, Pelaez C, LaloiM, Cleusix V, et al. 2004. Hydrolysis of oligofructoses by the recombinant -fructofuranosidase from Bifidobacterium lactis. Syst. Appl. Microbiol. 27:279-85
46. JohanssonME, Larsson JM, Hansson GC. 2011. The two mucus layers of colon are organized by the MUC2
47. mucin, whereas the outer layer is a legislator of host-microbial interactions. PNAS 108(Suppl. 1):4659-65
48. Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, et al. 2004. Molecular cloning and characterization of Bifidobacterium bifidum 1,2-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J. Bacteriol. 186:4885-93
49. Kitaoka M, Tian J, Nishimoto M. 2005. Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl. Environ. Microbiol. 71:3158-62
50. Klaassens ES,Ben-AmorK,VriesemaA, Vaughan EE, de VosW. 2011. The fecal bifidobacterial transcriptome of adults: a microarray approach. Gut Microbes 2:217-26
51. Kullin B, Abratt VR, Reid SJ. 2006. A functional analysis of the Bifidobacterium longum cscA and scrP genes in sucrose utilization. Appl. Microbiol. Biotechnol. 72:975-81
52. Lagaert S, Pollet A, Delcour JA, Lavigne R, Courtin CM, Volckaert G. 2010. Substrate specificity of three recombinant -L-arabinofuranosidases from Bifidobacterium adolescentis and their divergent action on arabinoxylan and arabinoxylan oligosaccharides. Biochem. Biophys. Res. Commun. 402:644-50
53. Le Bougúenec C, Schouler C. 2011. Sugar metabolism, an additional virulence factor in enterobacteria. Int. J. Med. Microbiol. 301:1-6
54. Lee JH, O'Sullivan DJ. 2010. Genomic insights into bifidobacteria. Microbiol. Mol. Biol. Rev. 74:378-416
55. Likotrafiti E, Tuohy KM, Gibson GR, Rastall RA. 2014. An in vitro study of the effect of probiotics, prebiotics and synbiotics on the elderly faecal microbiota. Anaerobe 27:50-55
56. LinkeCM, Woodiga SA,Meyers DJ, Buckwalter CM, SalhiHE, King SJ. 2013. The ABC transporter encoded at the pneumococcal fructooligosaccharide utilization locus determines the ability to utilize long-and short-chain fructooligosaccharides. J. Bacteriol. 195:1031-41
57. LoCascio RG, Desai P, Sela DA, Weimer B, Mills DA. 2010. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Appl. Environ. Microbiol. 76:7373-81
58. Mäkeläinen H, Hasselwander O, Rautonen N, Ouwehand AC. 2009. Panose, a new prebiotic candidate. Lett. Appl. Microbiol. 49:666-72
59. Mäkeläinen H, Saarinen M, Stowell J, Rautonen N, Ouwehand AC. 2010. Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures. Benef. Microbes 1:139-48
60. Makras L, Van Acker G, De Vuyst L. 2005. Lactobacillus paracasei subsp. paracasei 8700:2 degrades inulin-type fructans exhibiting different degrees of polymerization. Appl. Environ. Microbiol. 71:6531-37
61. Marcobal A, Barboza M, Froehlich JW, Block DE, German JB, et al. 2010. Consumption of human milk oligosaccharides by gut-related microbes. J. Agric. Food Chem. 58:5334-40
62. Møller MS, Fredslund F, Majumder A, Nakai H, Poulsen JCN, et al. 2012. Enzymology and structure of the GH13-31 glucan 1,6-glucosidase that confers isomaltooligosaccharide utilization in the probiotic Lactobacillus acidophilus NCFM. J. Bacteriol. 194:4249-59
63. Møller MS, Goh YJ, Viborg AH, Andersen JM, Klaenhammer TR, et al. 2014. Recent insight in -glucan metabolism in probiotic bacteria. Biologia 69:713-21
64. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, et al. 2002. Dosage-related bifidogenic effects of galactoand fructooligosaccharides in formula-fed term infants. J. Pediatr. Gastroenterol. Nutr. 34:291-95
65. Muramatsu K, Onodera S, Kikuchi M, Shiomi N. 1992. The production of -fructofuranosidase from Bifidobacterium spp. Biosci. Biotech. Biochem. 56:1451-54
66. Niness KR. 1999. Inulin and oligofructose: what are they? J. Nutr. 129:1402S-6S
67. NishimotoM, Kitaoka M. 2007. Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl. Environ. Microbiol. 73:6444-49
68. O'Connell Motherway M, Fitzgerald GF, Neirynck S, Ryan S, Steidler L, van Sinderen D. 2008. Characterization of ApuB, an extracellular type II amylopullulanase from Bifidobacterium breve UCC2003. Appl. Environ. Microbiol. 74:6271-79
69. O'Connell Motherway M, Fitzgerald GF, van Sinderen D. 2010. Metabolism of a plant derived galactosecontaining polysaccharide by Bifidobacterium breve UCC2003. Microb. Biotechnol. 4:403-16
70. O'Connell Motherway M, Kinsella M, Fitzgerald GF, van Sinderen D. 2013. Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003. Microb. Biotechnol. 6:67-79
71. O'Donnell MM, Forde BM, Neville B, Ross PR, O'Toole PW. 2011. Carbohydrate catabolic flexibility in the mammalian intestinal commensal Lactobacillus ruminis revealed by fermentation studies aligned to genome annotations. Microb. Cell Fact. 10(Suppl. 1):S12
72. Oku T, Tokunaga T, Hosoya N. 1984. Nondigestibility of a new sweetener, "Neosugar," in the rat. J. Nutr. 114:1574-81
73. Omori T, Ueno K, Muramatsu K, Kikuchi M, Onodera S, Shiomi N. 2010. Characterization of recombinant -fructofuranosidase from Bifidobacterium adolescentis G1. Chem. Cent. J. 4:9
74. Paludan-Müller C, Gram L, Rattray FP. 2002. Purification and characterisation of an extracellular fructan -fructosidase from a Lactobacillus pentosus strain isolated from fermented fish. Syst. Appl.Microbiol. 25:13-20
75. Parche S, Amon J, Jankovic I, Rezzonico E, Beleut M, et al. 2007. Sugar transport systems of Bifidobacterium longum NCC2705. J. Mol. Microbiol. Biotechnol. 12:9-19
76. Petschow B, Dore J, Hibberd P, DinanT, ReidG, et al. 2013. Probiotics, prebiotics, and the hostmicrobiome: the science of translation. Ann. N.Y. Acad. Sci. 1306:1-17
77. Pfeiler EA, Azcarate-Peril MA, Klaenhammer TR. 2007. Characterization of a novel bile-inducible operon encoding a two-component regulatory system in Lactobacillus acidophilus. J. Bacteriol. 189:4624-34
78. Porcheron G, Chanteloup NK, Trotereau A, Bree A, Schouler C. 2012. Effect of fructooligosaccharide metabolism on chicken colonization by an extra-intestinal pathogenic Escherichia coli strain. PLOS ONE 7:e35475
79. Porcheron G, Kut E, Canepa S, Maurel MC, Schouler C. 2011. Regulation of fructooligosaccharide metabolism in an extra-intestinal pathogenic Escherichia coli strain. Mol. Microbiol. 81:717-33
80. Rabiu BA, Jay AJ, Gibson GR, Rastall RA. 2001. Synthesis and fermentation properties of novel galactooligosaccharides by -galactosidases from Bifidobacterium species. Appl. Environ. Microbiol. 67:2526-30
81. Rossi M, Corradini C, Amaretti A, NicoliniM, Pompei A, et al. 2005. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl. Environ. Microbiol. 71:6150-58
82. Ryan SM, Fitzgerald GF, van Sinderen D. 2005. Transcriptional regulation and characterization of a novel -fructofuranosidase-encoding gene from Bifidobacterium breve UCC2003. Appl. Environ. Microbiol. 71:3475-82
83. Ryan SM, Fitzgerald GF, van Sinderen D. 2006. Screening for and identification of starch-, amylopectin-, and pullulan-degrading activities in bifidobacterial strains. Appl. Environ. Microbiol. 72:5289-96
84. Saito K, Kondo K, Kojima I, Yokota A, Tomita F. 2000. Purification and characterization of 2,6-D-fructan 6-levanbiohydrolase from Streptomyces exfoliatus F3-2. Appl. Environ. Microbiol. 66:252-56
85. SaulnierDM,Molenaar D, de VosWM, Gibson GR,Kolida S. 2007. Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 through microarrays. Appl. Environ. Microbiol. 73:1753-65
86. SchellMA,KarmirantzouM, SnelB, VilanovaD,BergerB, et al. 2002. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. PNAS 99:14422-27
87. Schouler C, Taki A, Chouikha I, Moulin-Schouleur M, Gilot P. 2009. A genomic island of an extraintestinal pathogenic Escherichia coli strain enables the metabolism of fructooligosaccharides, which improves intestinal colonization. J. Bacteriol. 191:388-93
88. Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, et al. 2008. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. PNAS 105:18964-69
89. Sela DA, Mills DA. 2010. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol. 18:298-307
90. ShinHY, Lee JH, Lee JY, Han YO, HanMJ, Kim DH. 2003. Purification and characterization of ginsenoside Ra-hydrolyzingD-xylosidase from Bifidobacterium breve K-110, a human intestinal anaerobic bacterium. Biol. Pharm. Bull. 26:1170-73
91. Tannock GW, Wilson CM, Loach D, Cook GM, Eason J, et al. 2012. Resource partitioning in relation to cohabitation of Lactobacillus species in the mouse forestomach. ISME J. 6:927-38
92. Tilg H, Moschen AR. 2014. Microbiota and diabetes: an evolving relationship. Gut 63:1513-21
93. Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, et al. 2010. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. PNAS 107:19514-19
94. Turroni F, VenturaM, Butto LF,Duranti S, O'Toole PW, et al. 2014. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell. Mol. Life Sci. 71:183-203
95. Urashima T, Asakuma S, Leo F, Fukuda K, Messer M, Oftedal OT. 2012. The predominance of type I oligosaccharides is a feature specific to human breast milk. Adv. Nutr. 3:473S-82S
96. Ventura M, O'Flaherty S, Claesson MJ, Turroni F, Klaenhammer TR, et al. 2009. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat. Rev. Microbiol. 7:61-71
97. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, et al. 2008. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl. Environ. Microbiol. 74:3996-4004
98. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. 2006. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl. Environ. Microbiol. 72:4497-99
99. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. 2007. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol. Nutr. Food Res. 51:1398-405
100. Xiao JZ,Takahashi S, NishimotoM,Odamaki T, Yaeshima T, et al. 2010. Distribution of in vitro fermentation ability of lacto-N-biose I, amajor building block of humanmilk oligosaccharides, in bifidobacterial strains. Appl. Environ. Microbiol. 76:54-59
101. Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, et al. 2007. Evolution of symbiotic bacteria in the distal human intestine. PLOS Biol. 5:e156
102. Yen CH, Tseng YH, Kuo YW, Lee MC, Chen HL. 2011. Long-term supplementation of isomaltooligosaccharides improved colonic microflora profile, bowel function, and blood cholesterol levels in constipated elderly people-a placebo-controlled, diet-controlled trial. Nutrition 27:445-50
103. YoshidaE, SakuramaH,KiyoharaM,NakajimaM,KitaokaM,et al. 2012. Bifidobacterium longum subsp. infantis uses two different -galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 22:361-68
104. Zeng H, Xue Y, Peng T, Shao W. 2007. Properties of xylanolytic enzyme system in bifidobacteria and their effects on the utilization of xylo-oligosaccharides. Food Chem. 101:1172-77